Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 29 April 2003
Vol. 2003, Issue 180, p. pe15
[DOI: 10.1126/stke.2003.180.pe15]


Calcium and the Failing Heart: Phospholamban, Good Guy or Bad Guy?

Robert H. G. Schwinger1* and Konrad F. Frank1

1Laboratory of Muscle Research and Molecular Cardiology, Department of Internal Medicine III, Joseph-Stelzmannstrasse, 50924 Köln, Germany.

Abstract: In cardiac cells, phospholamban is a potent inhibitor of sarcoplasmic reticulum calcium (Ca2+) transport. Overexpression of mutant forms of phospholamban may result in beneficial or detrimental effects on intracellular Ca2+ handling and cardiac systolic and diastolic function. Mutations in phospholamban have also been linked to human cardiomyopathies, providing important insights into the underlying disease mechanisms and the key role of phospholamban in myocardial excitation-contraction coupling. This Perspective discusses new advances in our understanding of the role of phospholamban in intracellular Ca2+ handling and the development of human and murine cardiomyopathies.

*Corresponding author. Robert H. G. Schwinger; telephone, +49 221 478 3138; fax, +49 221 478 3746; e-mail, robert.schwinger{at}

Citation: R. H. G. Schwinger, K. F. Frank, Calcium and the Failing Heart: Phospholamban, Good Guy or Bad Guy? Sci. STKE 2003, pe15 (2003).

Read the Full Text

Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A.
K. TASKEN and E. M. AANDAHL (2004)
Physiol Rev 84, 137-167
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882